Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease - authors' reply

被引：1
|
作者：
Wang, W. [1 ]
Indik, S. [2 ]
Wong, G. K-S [1 ,3 ,4 ,5 ]
Mason, A. L. [1 ,5 ]
机构：
[1] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada
[2] Univ Vet Med, Dept Virol, Vienna, Austria
[3] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada
[4] BGI Shenzhen, Shenzhen, Peoples R China
[5] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2015年 / 41卷 / 05期
关键词：
CIRRHOSIS; VIRUS;
D O I：
10.1111/apt.13082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：491 / 491
页数：1
相关论文
共 44 条
  • [1] Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease
    Tabibian, J. H.
    Lindor, K. D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 490 - 490
  • [2] Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease
    Wang, W.
    Indik, S.
    Wasilenko, S. T.
    Faschinger, A.
    Carpenter, E. J.
    Tian, Z.
    Zhang, Y.
    Wong, G. K. -S.
    Mason, A. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (04) : 393 - 405
  • [3] Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis
    Syed, Hussain
    Penner, Tara
    Mason, Andrew L.
    VIRUSES-BASEL, 2022, 14 (09):
  • [4] Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Authors' reply
    Sorda, Juan Antonio
    Gonzalez Ballerga, Esteban
    Barreyro, Fernando Javier
    Daruich, Jorge
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (02) : 249 - 250
  • [5] Autoimmune liver disease-related autoantibodies in patients with biliary atresia
    Pang, Shu-Yin
    Dai, Yu-Mei
    Zhang, Rui-Zhong
    Chen, Yi-Hao
    Peng, Xiao-Fang
    Fu, Jie
    Chen, Zheng-Rong
    Liu, Yun-Feng
    Yang, Li-Yuan
    Wen, Zhe
    Yu, Jia-Kang
    Liu, Hai-Ying
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (03) : 387 - 396
  • [6] Editorial: scoring systems in primary biliary cholangitis - time to make a move. Authors' reply
    Yang, F.
    Yang, Y.
    Tang, R.
    Gershwin, M. E.
    Ma, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) : 1164 - 1165
  • [7] Authors' Reply to Rolland et al.: "Management of Alcohol Dependence in Patients with Liver Disease"
    Addolorato, Giovanni
    Mirijello, Antonio
    CNS DRUGS, 2013, 27 (10) : 865 - 866
  • [8] Editorial: surviving your genesthe role of PNPLA3 variation in end-stage liver disease. Authors' reply
    Mandorfer, Mattias
    Scheiner, Bernhard
    Reiberger, Thomas
    Ferlitsch, Arnulf
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (07) : 775 - 776
  • [9] Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease
    Suri, Jaspreet S.
    Danford, Christopher J.
    Patwardhan, Vilas
    Bonder, Alan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [10] Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis
    Fujino, Hatsue
    Tanaka, Mio
    Imamura, Michio
    Morio, Kei
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Takahashi, Shoichi
    Miki, Daiki
    Tsuge, Masataka
    Hiramatsu, Akira
    Aikata, Hiroshi
    Hayes, C. Nelson
    Chayama, Kazuaki
    BMC GASTROENTEROLOGY, 2019, 19 (01)
12345